An Israeli airstrike on medicine warehouses in central Gaza has stripped the territory’s collapsing health system of some of its last pharmaceutical reserves, accelerating what Gaza’s own Health Ministry describes as a slow, preventable death toll among patients who can no longer receive treatment. The destruction of two major storage facilities in Deir al-Balah — a city in central Gaza that has served as a critical logistical hub for humanitarian operations — represents not merely a material loss but, in the assessment of Palestinian health authorities, a sentence carried out against the chronically ill, the post-operative, and the dying.
What Happened
An Israeli strike hit two major medicine warehouses in Deir al-Balah, destroying stockpiles that had been supplying medical facilities across the Gaza Strip. The attack is the latest in a documented pattern of strikes targeting or damaging health infrastructure in Gaza. Gaza’s Health Ministry, the primary authority tracking the humanitarian health toll inside the territory, confirmed the destruction and warned that medicine shortages resulting from the cumulative campaign are now killing three cancer patients per day — patients whose deaths are directly attributable to the absence of drugs that would otherwise be available to them.
Deir al-Balah has taken on particular significance during the current period of the war as a staging ground for what little humanitarian activity has been able to continue amid access restrictions and active hostilities. The loss of warehoused medicine there is therefore not localised; it ripples across whatever remains of Gaza’s distribution network.
Who Is Affected
The immediate victims of the warehouse destruction are patients — those with cancer, chronic illness, post-surgical needs, and acute conditions — who depend on a functioning pharmaceutical supply chain that no longer reliably exists. Gaza’s Health Ministry’s figure of three cancer deaths per day attributable to medicine shortages points to a category of mortality that does not appear in airstrike casualty counts but is no less a consequence of the conflict’s conduct.
Healthcare workers, already operating in facilities that have been damaged, besieged, or forced to shut down over the course of the war, face the compounding burden of watching patients deteriorate without the means to intervene. Hospitals across Gaza have cycled through crises of fuel, surgical supplies, anaesthetics, and blood products throughout the conflict. Pharmaceutical warehouses represented one of the few points in the system where bulk capacity could be stored and redistributed. Their destruction forecloses that option.
The Wider Pattern
The strike on Deir al-Balah’s medicine stores is consistent with a pattern that human rights organisations have been documenting since the beginning of the current phase of hostilities. The World Health Organization, OCHA, and monitors including Al-Haq and Euro-Med Human Rights Monitor have repeatedly recorded strikes on or near hospitals, ambulances, and medical personnel in Gaza. Under international humanitarian law — specifically the Geneva Conventions and their Additional Protocols — medical facilities and supplies enjoy protected status and may not be targeted. Deliberate attacks on such infrastructure constitute war crimes under that framework.
Gaza entered the current conflict with a health system already weakened by nearly two decades of blockade. The blockade, maintained by Israel and Egypt, has chronically restricted the import of medicines, medical equipment, and spare parts for hospital machinery. What the warehouses in Deir al-Balah held was, in many cases, already a fraction of what Gaza’s population of more than two million people required.
What Primary-Source Monitors Say
The UN Office for the Coordination of Humanitarian Affairs (OCHA) has consistently flagged Gaza’s health system as being at or beyond the point of collapse, noting in successive situation reports the destruction of hospitals and the inability of humanitarian convoys to reliably deliver medical supplies. Amnesty International and Human Rights Watch have both documented the targeting of health infrastructure and called for independent investigations. The Gaza Health Ministry, while operating under extraordinary duress, remains the primary source of in-territory casualty and health-system data and has issued repeated warnings about pharmaceutical shortfalls. Its figure of three cancer deaths per day from medicine shortages is a metric of slow attrition that sits alongside, and is inseparable from, the broader toll of the war.
What to Watch Next
The immediate questions are whether replacement medical supplies can reach central Gaza — through whatever humanitarian corridors remain open or are negotiated — before the gap in pharmaceutical stocks costs more lives, and whether international monitors will be granted the access needed to document the full extent of the warehouse destruction and its medical consequences. Longer term, the cumulative destruction of health infrastructure raises questions about Gaza’s capacity to function as a viable health system at any point in the foreseeable future, regardless of when hostilities cease.
The phrase “silent extermination,” invoked to describe the medicine crisis, captures what Palestinian health authorities are asserting: that the deaths accumulating among cancer patients and other chronically ill people in Gaza are not incidental to the conflict but are a foreseeable, documented, and ongoing result of strikes on the infrastructure that keeps people alive.
—
Palestinian writer and researcher documenting life under occupation, drawing on primary sources from B’Tselem, Al-Haq, OCHA oPt, Amnesty, Human Rights Watch, and named scholars.